TY - JOUR
T1 - Improving research for prostate cancer survivorship
T2 - A statement from the Survivorship Research in Prostate Cancer (SuRECaP) working group
AU - Narayan, Vivek
AU - Harrison, Michael
AU - Cheng, Heather
AU - Kenfield, Stacey
AU - Aggarwal, Rahul
AU - Kwon, Daniel
AU - McKay, Rana
AU - Hauger, Richard
AU - Hart, Nicolas
AU - Conzen, Suzanne
AU - Borno, Hala
AU - Jim, Heather
AU - Dicker, Adam
AU - Dorff, Tanya
AU - Moslehi, Javid
AU - Mucci, Lorelei
AU - Parsons, J. Kellogg
AU - Saad, Fred
AU - Soule, Howard
AU - Morgans, Alicia
AU - Ryan, Charles J.
N1 - Funding Information:
The authors wish to acknowledge the Prostate Cancer Foundation for supporting the development of the Survivorship Research in Prostate Cancer Working Group (SuRECaP), as well as ongoing prostate cancer survivorship research.
Publisher Copyright:
© 2019
PY - 2020/3
Y1 - 2020/3
N2 - Survivorship care for patients with prostate cancer requires careful consideration of unique disease-specific factors, including the prolonged natural disease history, the potential for competing health risks, and the consequences of long-term androgen deprivation therapy. However, current prostate cancer survivorship research is unfortunately limited by the lack of a robust supportive evidence base, variability in the definitions and measurement of survivorship outcomes, and a heavy reliance on expert opinion. As a result, the conduct of quality prostate cancer survivorship research is of increasing importance for patients, medical providers, and other key stakeholders. This manuscript harmonizes a path forward for improving prostate cancer survivorship by defining prostate cancer survivorship and survivorship research, as well as by highlighting key research priorities and cooperative mechanisms for survivorship studies within prostate cancer, with a particular focus on men with advanced disease.
AB - Survivorship care for patients with prostate cancer requires careful consideration of unique disease-specific factors, including the prolonged natural disease history, the potential for competing health risks, and the consequences of long-term androgen deprivation therapy. However, current prostate cancer survivorship research is unfortunately limited by the lack of a robust supportive evidence base, variability in the definitions and measurement of survivorship outcomes, and a heavy reliance on expert opinion. As a result, the conduct of quality prostate cancer survivorship research is of increasing importance for patients, medical providers, and other key stakeholders. This manuscript harmonizes a path forward for improving prostate cancer survivorship by defining prostate cancer survivorship and survivorship research, as well as by highlighting key research priorities and cooperative mechanisms for survivorship studies within prostate cancer, with a particular focus on men with advanced disease.
KW - Improving research
KW - Prostate cancer
KW - Prostate cancer survivorship
KW - Survivorship
UR - http://www.scopus.com/inward/record.url?scp=85075453335&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85075453335&partnerID=8YFLogxK
U2 - 10.1016/j.urolonc.2019.10.006
DO - 10.1016/j.urolonc.2019.10.006
M3 - Review article
C2 - 31734020
AN - SCOPUS:85075453335
SN - 1078-1439
VL - 38
SP - 83
EP - 93
JO - Urologic Oncology: Seminars and Original Investigations
JF - Urologic Oncology: Seminars and Original Investigations
IS - 3
ER -
